Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Scheraga is an Associate Staff Physician at the Respiratory Institute and holds a secondary appointment in the Lerner Research Institute Department of Pathobiology, where her research focus is Acute Lung Injury and Idiopathic Pulmonary Fibrosis (IPF). In the laboratory of Dr. Mitchell Olman, Dr. Scheraga has started to investigate the role of a calcium ion channel in macrophage function and activation. Determining the molecular mechanisms of immunologic function will aid in the treatment of multiple diseases. Her current research is focused on targeting unregulated pulmonary inflammation leading to tissue injury and fibrosis. In addition, Dr. Scheraga treats patients in the medical intensive care unit where patients develop progressive lung injury for which there is no current treatment. She also supervises trainees in the intensive care unit and teaches medical students about the immunology of pulmonary infections where she is Assistant Professor of Medicine in the Cleveland Clinic Lerner College of Medicine.
Since joining the staff of the Cleveland Clinic in 2013, Dr.Scheraga has been invited to present her research findings as a late-breaking abstract at the American Thoracic Society International Conference and American Society of Matrix Biology. She reviews manuscripts for the American Journal of Respiratory and Critical Care Medicine and was asked to write an invited Editorial.
American Thoracic Society, American Society for Matrix Biology, American College of Chest Physician, Society of Critical Care Medicine
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 3/7/2014, Dr. Scheraga has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.